Financial Insights That Matter
PARIS (Reuters) -France’s finance minister criticised on Thursday a decision by French drugmaker Sanofi to invest at least $20 billion in the United States through to 2030, as France aims to get more companies investing in the country rather than abroad.
“It’s clear it was not something that was nice to see and it was an unpleasant announcement,” finance minister Eric Lombard told BFM Business TV.
“It sends out a bad signal,” he also said, adding he hoped Sanofi would continue to invest in France.
The French drugmaker, one of the world’s largest vaccine makers and a leader in anti-inflammatory drugs, said on Wednesday that it planned to expand its U.S. manufacturing capacity through direct investments in Sanofi sites, and partnerships with other domestic manufacturers.
Sanofi’s decision was the latest one from leading drugmakers which have been expanding their U.S. presence in response to President Donald Trump’s trade policies.
(Reporting by Sudip Kar-Gupta;Editing by Benoit Van Overstraeten)
#1a73e8;">Boost Your Financial Knowledge and Achieve Stability
Discover a growing online community dedicated to delivering financial news, tips, and strategies designed to help you manage money effectively, save smarter, and grow your investments with confidence.
#1a73e8;">Top Financial Tips for Saving and Investing
- Personal Finance Management: Master the art of budgeting, expense tracking, and building a strong financial foundation.
- Investment Opportunities: Stay updated on market trends, learn about stocks, and explore secure ways to grow your wealth.
- Expert Money-Saving Advice: Access proven techniques to reduce expenses and maximize your financial potential.